US2014011964A1PendingUtilityA1
Activated Polyoxazolines and Conjugates and Compositions Comprising the Same
Est. expiryFeb 28, 2027(~0.6 yrs left)· nominal 20-yr term from priority
Inventors:J. Milton HarrisMichael D. BentleyKunsang YoonZhihao FangFrancesco Maria VeroneseTacey X. ViegasAnna Mero
A61K 38/1719C08G 69/48A61K 31/727A61K 38/42A61K 31/728C12N 9/96A61K 38/10A61K 38/1816C07K 14/535C12Y 302/01017A61K 38/33A61K 38/193A61K 38/27A61K 47/59C07K 14/47C07K 7/08C07K 14/505A61K 38/47C07K 14/62A61K 47/48207
67
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present disclosure provides POZ derivatives having a range of active functional groups allowing conjugation of POZ derivatives to a variety of target molecules under a wide range of reaction conditions to produce a hydrolytically stable target molecule-POZ conjugate. Furthermore, the present disclosure provides novel methods of synthesis for the disclosed POZ derivatives and hydrolytically stable target molecule-POZ conjugates created using the disclosed terminally activated monofunctional POZ derivatives. In one embodiment, the POZ derivative is a terminally activated monofunctional POZ derivative.
Claims
exact text as granted — not AI-modifiedWhat is claimed:
1 . A terminally activated polyoxazoline (POZ) compound of the general structure R 1 —[N(COR 7 )CH 2 CH 2 ] n -P p -Q q -X,
wherein:
X is an active functional group capable of forming a linkage with a target molecule to form a target molecule-POZ conjugate wherein all the linkages between the target molecule and the POZ compound are stable in a biological system;
P is a linking group selected from the group consisting of —O—, NH or —NR 11 —;
Q is an optional linking group;
R 7 is independently selected for each repeating unit of POZ from an unsubstituted or substituted alkyl, alkenyl or aralkyl group;
R 1 and R 11 are each independently hydrogen, unsubstituted or substituted alkyl, alkenyl or aralkyl group or R 11 and the N to which it is connected from a 5 or 6 membered heterocycle ring, which may be further substituted with 1 additional N atom;
n is an integer from 3 to 1000; and
p and q are integers independently selected from zero or one
2 . The compound of claim 1 , wherein the active functional group is protected.
3 . The compound of claim 1 , wherein R 7 is methyl, ethyl or n-propyl.
4 . The compounds of claim 1 , wherein the active functional group is selected from the group consisting of: aldehydes, active carbonates, maleimides, sulfonate esters, tresylate, mesylate, hydrazide, epoxides, iodoacetamides, alkynes, azides, isocyanates, cyanates isothiocyanates, thiocyanates, nitriles, carbonyldiimidazole derivatives, vinylsulfones, carboxylic acid halides, active esters and carboxylic acids.
5 . The compound of claim 1 , wherein NR 11 together form a substituted or unsubstituted piperazinyl or a substituted or unsubstituted piperidinyl group.
6 . The compound of claim 1 , wherein the POZ polymer has a polydispersity value of less than or equal to 1.2, less than or equal to 1.1 or less than or equal to 1.05.
7 . The compound of claim 1 , wherein Q is an unsubstituted or substituted alkyl, alkenyl, aralkyl, heterocyclyl or aryl group, —(CH 2 ) m —CONH—(CH 2 ) m —, —NH—(CH 2 ) m —NHCO—(CH 2 ) m —, —CO—(CH 2 ) m —, —CO—C 6 H 4 —, or —CO—R 8 , —(R 15 ) m — or —(CR 3 R 4 ) m —, where R 3 -R 4 and R 15 are each independently selected from hydrogen, unsubstituted or substituted alkyl, alkenyl or aralkyl group, R 8 is —C 6 H 10 —CH 2 — and m is an integer from 1 to 10.
8 . A target molecule POZ conjugate of the general formula A-B-TM, wherein
A is a POZ compound of claim 1 minus any leaving groups eliminated during the reaction of the active functional group on the POZ compound with a binding partner on a target molecule; TM is the target molecule, said target molecule containing the binding partner; and B is a linkage formed between the POZ compound and the binding partner, the linkage being stable in a biological system.
9 . The conjugate of claim 8 , wherein the active functional group is a tresylate, the binding partner is SH and B is a thioether linkage.
10 . The conjugate of claim 8 , wherein the active functional group is a maleimide, the binding partner is SH and B is a thioether linkage.
11 . The conjugate of claim 8 , wherein the active functional group is an active carbonate, the binding partner is NH 2 and B is a urethane linkage.
12 . The conjugate of claim 8 , wherein the active functional group is an active ester, the binding partner is NH 2 and B is an amide linkage.
13 . The conjugate of claim 8 , wherein the active functional group is an aldehyde, the binding partner is NH 2 and B is an amine linkage.
14 . The conjugate of claim 8 , wherein the POZ compound has a polydispersity value of less than or equal to 1.2, less than or equal to 1.1 or less than or equal to 1.05.
15 . The conjugate of claim 8 , wherein the in vivo half-life of the target molecule-POZ conjugate is increased under physiological conditions.
16 . The conjugate of claim 15 , wherein the POZ polymer has a polydispersity value of less than or equal to 1.2, less than or equal to 1.1 or less than or equal to 1.05.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.